Skip to content
Dr Zarir F. Udwadia
  • Home
  • About
    • Achievements
    • Publications
    • Highlights
    • News & Updates
  • Gallery
  • Patient Information
    • Asthma
    • COPD/Emphysema
    • Bronchiectasis
    • Interstitial Lung Disease
    • Idiopathic Pulmonary Fibrosis
    • Sarcoidosis
    • Tuberculosis
    • Multi-drug resistant tuberculosis
    • Obstructive Sleep Apnea Syndrome
  • Contact
  • Corona Updates
Menu

Corrigendum to “Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables” [Int. J. Mycobacteriol. 5(1) 2016 1-6].

Go to Publication

You Might Also Like

Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.

April 10, 2012

Few eligible for the newly recommended short course MDR TB regimen at a large Mumbai private clinic.

August 30, 2019

Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us

January 9, 2020

Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutations.

October 19, 2015

Pneumocystis carinii pneumonia in HIV infected patients from Mumbai.

May 16, 2005

Hinduja Hospital,

Mahim, Mumbai – 400016

Appointment –
022 45108181, 022 67668181

Office – 022 24447353

Breach Candy Hospital,

B. Desai Road, Mumbai – 400026

Appointment – 5-8 pm
022 23667900
022 23667995

 

Thomas Cook Building,

DN Road, Mumbai – 400001

Appointment – After 6 pm
022 22046210
022 67439337

Copyright 2025 - Dr.Zarir Udwadia
Close Menu